Coronavirus Vaccine Contender CureVac Files to Go Public in U.S.

(Bloomberg) -- CureVac, a competitor in the race for a coronavirus vaccine, has filed for an initial public offering in the U.S.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.